全文获取类型
收费全文 | 37052篇 |
免费 | 2974篇 |
国内免费 | 807篇 |
专业分类
耳鼻咽喉 | 470篇 |
儿科学 | 733篇 |
妇产科学 | 757篇 |
基础医学 | 3085篇 |
口腔科学 | 552篇 |
临床医学 | 3382篇 |
内科学 | 6907篇 |
皮肤病学 | 653篇 |
神经病学 | 1011篇 |
特种医学 | 1609篇 |
外国民族医学 | 22篇 |
外科学 | 5882篇 |
综合类 | 3477篇 |
现状与发展 | 2篇 |
预防医学 | 2270篇 |
眼科学 | 599篇 |
药学 | 2383篇 |
9篇 | |
中国医学 | 397篇 |
肿瘤学 | 6633篇 |
出版年
2024年 | 99篇 |
2023年 | 1075篇 |
2022年 | 1882篇 |
2021年 | 2453篇 |
2020年 | 2039篇 |
2019年 | 2198篇 |
2018年 | 2017篇 |
2017年 | 1413篇 |
2016年 | 1238篇 |
2015年 | 1231篇 |
2014年 | 2446篇 |
2013年 | 2226篇 |
2012年 | 1650篇 |
2011年 | 1903篇 |
2010年 | 1515篇 |
2009年 | 1534篇 |
2008年 | 1677篇 |
2007年 | 1665篇 |
2006年 | 1323篇 |
2005年 | 1212篇 |
2004年 | 1019篇 |
2003年 | 886篇 |
2002年 | 759篇 |
2001年 | 589篇 |
2000年 | 510篇 |
1999年 | 449篇 |
1998年 | 414篇 |
1997年 | 340篇 |
1996年 | 294篇 |
1995年 | 268篇 |
1994年 | 269篇 |
1993年 | 211篇 |
1992年 | 228篇 |
1991年 | 206篇 |
1990年 | 177篇 |
1989年 | 157篇 |
1988年 | 152篇 |
1987年 | 130篇 |
1986年 | 124篇 |
1985年 | 147篇 |
1984年 | 130篇 |
1983年 | 88篇 |
1982年 | 102篇 |
1981年 | 82篇 |
1980年 | 77篇 |
1979年 | 61篇 |
1978年 | 46篇 |
1977年 | 52篇 |
1976年 | 31篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
434例肺癌淋巴结转移及其廓清的临床研究 总被引:1,自引:0,他引:1
目的:研究肺癌淋巴结转移的方式与规律,以探讨肺癌淋巴结合理的手术廓清范围。方法:对434例肺癌患者施行手术并予淋巴结廓清,回顾性分析病理证实的转移淋巴结的分布情况。结果:手术共清除2198组淋巴结,病理证实有癌细胞转移的749组。淋巴结转移率T1期为16.5%,T2期33.5%,T3期35.6%,T4期52.3%,T1期和T4期的组间有显著性差异(P<0.01)。上叶肺癌上纵膈与下纵膈淋巴结转移有显著差异。左上叶肺癌第5组淋巴结有30.6%转移,左下叶和右中、下叶肺癌第7组淋巴结有26.5%转移。结论:除T1期肺癌淋巴结转移仅限于区域性上纵膈或下纵膈外,总体上,上叶肺癌以上纵膈淋巴结转移居多,而中、下叶肺癌则上、下纵膈均可发生淋巴结转移。左上叶肺癌第5组淋巴结转移和中、下叶肺癌第7组淋巴结转移是上、下纵膈之间淋巴结扩大转移的信号。原发肺癌除T1期可仅行区域性上纵膈或下纵膈淋巴结清扫外,均应行系统性肺门和上下纵膈淋巴结廓清。 相似文献
82.
MMP-9和TIMP-1表达失衡与乳腺癌浸润、转移的相关性 总被引:2,自引:0,他引:2
目的 研究乳腺癌组织中基质金属蛋白酶(MMP-9)和金属蛋白酶组织抑制因子(TIMP-1)的表达变化与乳腺癌生物学行为及淋巴结转移的关系。方法 应用SP免疫组织化学方法检测85例乳腺癌组织MMP-9,TIMP-1及细胞增殖核抗原ki-67的表达情况。结果 MMP-9阳性染色率90.59%,MMP-9阳性表达与肿瘤浸润,淋巴结转移,ki-67指数及TNM分期呈正相关(Pearson列联系数分别为P=0.03,P=0.02,P=0.004和P=0.0000,P<0.05,0.01。TIMP-1阳性染色率为78.82%,TIMP-1阳性表达与肿瘤浸润,淋巴结转移及TNM分期浸润,转移及ki-67指数显著相关(P<0.05,P<0.01,P<0.001)。结论 MMP-9和TIMP-1表达失衡与乳腺癌浸润及淋巴结转移密切相关。 相似文献
83.
84.
目的:分析T1期(肿瘤直径<2cm)原发性乳腺癌女性患者绝经前后在肿瘤大小、病理分类、淋巴结转移率和数目。方法:常规病理检验以及应用免疫组化、HE法分别测定绝经前乳腺癌患者和绝经后乳腺癌患者者的ER、PR。结果:两组患者在肿瘤大小上无明显差异,但绝经前乳腺癌患者浸润导管癌的百分比为 84. 7%,绝经后乳腺癌患者的浸润导管癌百分比为 62. 2%,经χ2 检验,P<0. 01。两组淋巴结转移率分别为 39. 3%和 25. 5%,经χ2 检验,P<0. 01。两组ER和PR阳性伴淋巴结转移的比例经χ2 检验,P<0. 05。结论:绝经前乳腺癌患者和绝经后乳腺癌患者在病理分类、淋巴结转移率及数目、ER、PR阳性伴淋巴结转移上有显著性差异。对于T1原发性乳腺癌患者不论有无淋巴结转移,均应行癌肿切除伴Ⅰ、Ⅱ级淋巴结清扫。 相似文献
85.
Immune modulation by cadmium and lead in the acute reporter antigen-popliteal lymph node assay. 总被引:2,自引:0,他引:2
Immune modulation by heavy metals may cause serious adverse health effects in humans, although the mechanisms involved are not well understood. Both cadmium and lead are important environmental and occupational toxins. Therefore, in the current study, the costimulatory/adjuvant effects and the T-cell-activating potential of these metals (i.e., CdCl2 and PbCl2), are examined. These immune-modulating properties are critical in the development of conditions such as allergy, hypersensitivity, and autoimmunity. Using the direct popliteal lymph node assay (PLNA) and reporter antigen-popliteal lymph node assay (RA-PLNA) both metals were examined individually for immunotoxicity. Mercury (i.e., HgCl2) was included for comparative purposes as its effects in the RA-PLNA are well documented. Seven days following a single footpad injection containing metal and/or RA (trinitrophenyl-ovalbumin [TNP-OVA] or TNP-Ficoll), BALB/c mice were sacrificed and the popliteal lymph nodes (PLNs) removed. PLN cellularity, TNP-specific antibody-secreting cells (ASCs), and lymphocyte subsets were assessed. All three metals strongly stimulated T- and B-cell proliferation and ASC production following coinjection with the RA TNP-OVA. In each case, ASC production was skewed towards the IgG1 isotype. In addition, all three metals induced IgG production to TNP-Ficoll (although relatively weakly in the case of Cd). These results show that each of these metals can provide adjuvant signals to promote lymphocyte proliferation and enhance adaptive immune responses to unrelated antigens. Skewing of immune responses towards T helper type 2 responses suggests that each of these metals can enhance allergic and hypersensitivity reactions to environmental antigens. Furthermore, the induction of IgG responses to TNP-Ficoll, a T-cell-independent antigen, indicates that each of these metals can activate neoantigen-specific T cells. T-cell activation by metals can lead to metal hypersensitivity and has been implicated in the development of autoimmunity. This is the first report of immune modulation by CdCl2 and PbCl2 in the RA-PLNA. 相似文献
86.
C. Fischer W. Gross J. Krüger M. Cremer F. Vogel T. Grimm 《Annals of human genetics》2006,70(2):237-248
For several genetic diseases two biological phenomena have been recognised as important: germline mosaicism; and different new mutation rates in males and females depending on mutation type. Both principles have been investigated separately and their influence on risk estimation in families has been exemplified in the literature. The aim of this paper is to present a general model that includes mosaicism and different new mutation rates. Mosaicism is introduced by defining additional alleles at the disease locus in combination with adapted segregation rules. Taking Duchenne muscular dystrophy as an example, we derive the conditions which have to be fulfilled for a population in mutation selection equilibrium. Our approach describes the model at the population level and not in individual subjects. This has the advantage of being able to use well known algorithms for the calculation of likelihoods in pedigrees, and to include additional diagnostic information such as marker genotypes and carrier deletion test results. We demonstrate the impact of the new model on a typical pedigree. In families where the patient is not available, the distinction between point mutations and deletions is important, since often molecular diagnostic tests for females can only screen for deletions. Negative deletion test results can now be included in the risk calculations. 相似文献
87.
Lin Bo Wang Jian Guo Shen Li Feng Dong Chao Yang Xu Wen Jun Chen Shu Duo Xie Xiang Yang Song Ning Dai Xiao Ming Yuan 《Journal of gastrointestinal surgery》2008,12(8):1359-1363
We previously reported that lymphatic mapping using isosulfan blue can be used to identify sentinel nodes (SNs). This study
was undertaken to evaluate the feasibility of using the SN technique in treating early gastric cancer and to explore its usefulness
for minimal invasive surgery. Twenty-three patients with early gastric cancer who underwent SN biopsy were retrospectively
evaluated. Based on SN evaluation, individualized surgery was performed in five patients with T1N0M0 gastric cancer. When
pathological examination of frozen sections revealed metastasis in SNs, we performed a standard D2 gastrectomy. Laparoscopic
local resection was applied when the SN biopsy was negative. Our results showed that the success rate with SN biopsy in early
gastric cancer was 100%, as were the accuracy, sensitivity, and specificity. All five patients with early gastric cancer had
SNs negative for metastases both by frozen section and by postoperative pathology. Thus, all these patients underwent laparoscopic
local resection without extended lymphadenectomy. We conclude that SN biopsy is a useful tool to individualize the operative
procedure, and laparoscopic local resection can be safely performed using SN guidance in selected patients with early gastric
cancer. 相似文献
88.
目的:观察密盖息(鲑鱼降钙素)的治疗骨转移瘤疼痛和血清钙的临床疗效。方法:单用组用密盖息100IU,肌肉注射,每日2次,共7d。联合化疗组化疗后加密盖息100IU肌肉注射,每日2次,每次7d。治疗结束进行疗效评价。结果:单用组骨痛完全缓解66.7%(12/18)。联合化疗组骨痛完全缓解率87.1%(27/31)。单用组血钙降至正常,占77.8%(14/18),联合化疗组血钙完全降至正常占100%(31/31)。副作用是暂时性的心动过速、皮肤潮红、头晕、恶心呕吐,无需特殊处理,自行缓解。结论:密盖息治疗骨转移瘤有止痛、降低血钙作用良好,副作用小,可以在临床上安全使用。 相似文献
89.
90.
Cholangiocarcinomas (CC) frequently demonstrate lymphatic spread. We investigated lymph node (LN) counts after resection of
extrahepatic CC and survival based on the SEER 1973–2004 database. Out of 20,068 CC patients, 1,518 individuals were selected
based on M0 stage and at least one LN examined. Primary cancer sites included gallbladder (29%), extrahepatic bile ducts (26%),
and intrapancreatic/ampullary bile ducts (45%); 42% of patients were LN-positive. The median number of LNs examined was four
(range 1–39). Median survival was 37 months for LN-negative and 16 months for LN-positive cancers. Multivariate prognostic
variables were the number of positive LNs, primary site, age (all at p < 0.0001), gender (p = 0.002), size (p = 0.005), T category (p = 0.009), and total LN count (or number of negative LNs obtained, p = 0.01). The impact of total LN counts was seen in LN-negative (median survival, 1 vs 10 or more LNs examined: 27 vs 51 months,
p = 0.002) and LN-positive disease (10 vs 22 months, p < 0.0001). Survival prediction of extrahepatic CCs is strongly influenced by total LN counts and numbers of negative LNs
obtained. Although the resulting incremental benefit is small, dissection and examination of 10 or more LNs should be considered
for curative intent resections. 相似文献